Research across Aortic Valve Disease
Related studies from across the Aortic Valve Disease family.
38 trials tracked for Aortic Valve Stenosis: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 282 citations.
Showing the 38 most-cited and recently-updated of 38 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Transcatheter Aortic Valve Replacement (TAVR) is associated with a 3% all-cause mortality rate and a 2% cardiovascular mortality rate at 30 days post-procedure, with no reported instances of stroke during this period 1. This procedure is established as a clinical intervention for the condition [1, 7].
Pharmacological management with Acetylsalicylic acid demonstrated significant results in improving aortic valve hemodynamics; specifically, it was associated with a reduction in leaflet motion and an improvement in the transvalvular mean pressure gradient (p=0.01) 2.
AI synthesis of 3 cited trials, updated Jun 28, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Aortic Valve Disease family.